Exploring C2 and N6 Substituent Effects on Truncated 4′‐Thioadenosine Derivatives as Dual A2A and A3 Adenosine Receptor Ligands
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Siddhi D. Naik, Minjae Kim, Jiyoung Choi, Gibae Kim, Seung Woo Kim, Vikas R. Aswar, Sushil K. Tripathi, Vidyasagar Gaikwad, Jinha Yu, Lak Shin Jeong |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
por: Agata Zięba, et al.
Publicado: (2024)
por: Agata Zięba, et al.
Publicado: (2024)
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands
por: Lea Ueberham, et al.
Publicado: (2025)
por: Lea Ueberham, et al.
Publicado: (2025)
Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ‐1 Subunit of Voltage‐Gated Calcium Channel and the μ‐Opioid Receptor
por: Anita Wegert, et al.
Publicado: (2024)
por: Anita Wegert, et al.
Publicado: (2024)
Ligand‐Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4
por: Daria Kotlarek, et al.
Publicado: (2026)
por: Daria Kotlarek, et al.
Publicado: (2026)
Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction
por: Timoteo Delgado‐Maldonado, et al.
Publicado: (2026)
por: Timoteo Delgado‐Maldonado, et al.
Publicado: (2026)
Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1
por: Max E. Huber, et al.
Publicado: (2024)
por: Max E. Huber, et al.
Publicado: (2024)
Phloroglucinol Derivatives Exert Anti‐Inflammatory Effects and Attenuate Cognitive Impairment in LPS‐Induced Mouse Model
por: Jushin Kim, et al.
Publicado: (2024)
por: Jushin Kim, et al.
Publicado: (2024)
Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
por: Isabelle Lyothier, et al.
Publicado: (2025)
por: Isabelle Lyothier, et al.
Publicado: (2025)
Unraveling the Molecular Reason of Opposing Effects of α‐Mangostin and Norfluoxetine on TREK‐2 at the Same Binding Site
por: Gangrae Kim, et al.
Publicado: (2024)
por: Gangrae Kim, et al.
Publicado: (2024)
Front Cover: Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1 (ChemMedChem 20/2024)
por: Max E. Huber, et al.
Publicado: (2024)
por: Max E. Huber, et al.
Publicado: (2024)
A Facile Protocol for C(sp 2 )–C(sp 3 ) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands
por: Anita Maksutova, et al.
Publicado: (2025)
por: Anita Maksutova, et al.
Publicado: (2025)
Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9
por: Philipp Grosche, et al.
Publicado: (2024)
por: Philipp Grosche, et al.
Publicado: (2024)
Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer
por: Martina Capozza, et al.
Publicado: (2024)
por: Martina Capozza, et al.
Publicado: (2024)
Cyclic Peptides Radiopharmaceuticals: A Concise Review of Ligand Identification, Radiolabeling, and Clinical Progress
por: Xiushuang Yuan, et al.
Publicado: (2026)
por: Xiushuang Yuan, et al.
Publicado: (2026)
Protonation Effects in Protein‐Ligand Complexes – A Case Study of Endothiapepsin and Pepstatin A with Computational and Experimental Methods
por: Helge Vatheuer, et al.
Publicado: (2025)
por: Helge Vatheuer, et al.
Publicado: (2025)
Investigation of Muscarinic Acetylcholine Receptor M3 Activation in Atomistic Detail: A Chemist's Viewpoint
por: Matthäus Drabek, et al.
Publicado: (2024)
por: Matthäus Drabek, et al.
Publicado: (2024)
Leveraging Natural Product‐Inspired Antifungals to Investigate the Mechanism of Action of Peniciaculin A
por: Ingrid K. Wilt, et al.
Publicado: (2024)
por: Ingrid K. Wilt, et al.
Publicado: (2024)
Development of New Benzo[ b ]Thiophene‐2‐Carboxamide Derivatives as Advanced Glycation End‐Products Receptor (RAGE) Antagonists
por: Lisa Bonin, et al.
Publicado: (2025)
por: Lisa Bonin, et al.
Publicado: (2025)
Combinatorial Libraries of Bipodal Binders of the Insulin Receptor
por: Irena Selicharová, et al.
Publicado: (2024)
por: Irena Selicharová, et al.
Publicado: (2024)
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
por: Trent D. Ashton, et al.
Publicado: (2024)
por: Trent D. Ashton, et al.
Publicado: (2024)
Two Step One‐Pot Synthesis of 7‐Azaindole Linked 1,2,3‐Triazole Hybrids: In‐Vitro and In‐Silico Antimicrobial Evaluation
por: Kanika Sharma, et al.
Publicado: (2024)
por: Kanika Sharma, et al.
Publicado: (2024)
GDF15 Analogues Acting as GFRAL Ligands
por: Andrea Di Santo, et al.
Publicado: (2025)
por: Andrea Di Santo, et al.
Publicado: (2025)
Machine Learning‐Driven Discovery of GABA‐A Ligands with Pronounced Neuroprotective Efficacy and Resistance to P‐gp Efflux
por: Katarzyna Szafrańska, et al.
Publicado: (2025)
por: Katarzyna Szafrańska, et al.
Publicado: (2025)
Kainate Receptor Allosteric Modulators: State of the Art and Future Directions
por: Thomas Colson, et al.
Publicado: (2026)
por: Thomas Colson, et al.
Publicado: (2026)
Exploiting the 5‐Amino‐11H‐Indolo[3,2‐c]isoquinoline Core to Achieve Better G‐Quadruplex Ligands for Cancer Therapy
por: Israa M. Aljnadi, et al.
Publicado: (2025)
por: Israa M. Aljnadi, et al.
Publicado: (2025)
Targeting Inflammatory and Oncogenic Pathways: Cyclooxygenase‐2, Epidermal Growth Factor Receptor, and p38 Mitogen‐Activated Protein Kinase Inhibition by Pyrazolone Derivatives
por: Sevde Nur Biltekin Kaleli, et al.
Publicado: (2026)
por: Sevde Nur Biltekin Kaleli, et al.
Publicado: (2026)
Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System
por: Bircan Dinc, et al.
Publicado: (2026)
por: Bircan Dinc, et al.
Publicado: (2026)
Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations
por: Giorgio Di Paco, et al.
Publicado: (2024)
por: Giorgio Di Paco, et al.
Publicado: (2024)
Development of Styryl‐Modified 3,4‐Dihydropyrimidin‐2(1 H )‐ones as Potential Antitumor Agents
por: Konstantinos Panagoulias, et al.
Publicado: (2026)
por: Konstantinos Panagoulias, et al.
Publicado: (2026)
Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
por: Giovanna Pitasi, et al.
Publicado: (2025)
por: Giovanna Pitasi, et al.
Publicado: (2025)
Investigations on Antiproliferative Potential of Thiosemicarbazone Zn(II) Complexes: Design, Synthesis, and Density Functional Theory Studies on Structural Parameters
por: Shivendra K. Pandey, et al.
Publicado: (2025)
por: Shivendra K. Pandey, et al.
Publicado: (2025)
Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
por: Jieye Lin, et al.
Publicado: (2025)
por: Jieye Lin, et al.
Publicado: (2025)
Identification of Novel and Selective GPR39 Receptor Antagonists for the Treatment of Acute Myocardial Ischemia
por: Agostino Cianciulli, et al.
Publicado: (2025)
por: Agostino Cianciulli, et al.
Publicado: (2025)
Structural Development of Androgen Receptor Antagonists Using Phenylferrocene Framework as a Hydrophobic Pharmacophore
por: Kotaro Ochiai, et al.
Publicado: (2024)
por: Kotaro Ochiai, et al.
Publicado: (2024)
Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits
por: Sabrina Silva‐Mendonça, et al.
Publicado: (2026)
por: Sabrina Silva‐Mendonça, et al.
Publicado: (2026)
Fluorescence Detection of DNA/RNA G‐Quadruplexes (G4s) by Twice‐as‐Smart Ligands
por: Jiri Ledvinka, et al.
Publicado: (2025)
por: Jiri Ledvinka, et al.
Publicado: (2025)
The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
por: Vít Prouza, et al.
Publicado: (2025)
por: Vít Prouza, et al.
Publicado: (2025)
An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands
por: Wei Chen, et al.
Publicado: (2025)
por: Wei Chen, et al.
Publicado: (2025)
Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
por: Jochem Nelen, et al.
Publicado: (2026)
por: Jochem Nelen, et al.
Publicado: (2026)
Beyond the Toll‐Like Receptor 4. Structure‐Dependent Lipopolysaccharide Recognition Systems: How far are we?
por: Stefania De Chiara, et al.
Publicado: (2025)
por: Stefania De Chiara, et al.
Publicado: (2025)
Ejemplares similares
-
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
por: Agata Zięba, et al.
Publicado: (2024) -
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands
por: Lea Ueberham, et al.
Publicado: (2025) -
Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ‐1 Subunit of Voltage‐Gated Calcium Channel and the μ‐Opioid Receptor
por: Anita Wegert, et al.
Publicado: (2024) -
Ligand‐Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4
por: Daria Kotlarek, et al.
Publicado: (2026) -
Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction
por: Timoteo Delgado‐Maldonado, et al.
Publicado: (2026)